Programmed Death Ligand-1 Blocker


Durvalumab may treat:

Durvalumab desired effects:

  • Increased Immunologic Activity
  • Increased Cellular Death

Durvalumab drug classes:

  • Programmed Death Ligand-1 Blocker

Durvalumab pharmacologic actions:

  • Antineoplastic Agents, Immunological

Durvalumab mechanism of action:

  • Programmed Death Ligand-1 Antagonists
  • Programmed Death Ligand-1-directed Antibody Interactions
  • treatable

The content offered on Treatable.org is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 10/18/2022, 3:46:47 PM